Report title: Johnson & Johnson at Deutsche Bank Securities Inc. Health Care Conference Transcript
from Thomson StreetEvents
11 page (6156 word) report published May 05, 2008

Price $54.00 available for immediate download
Report Overview
 
Search Inside
 
About Thomson StreetEvents

Abstract: Final Transcript of JNJ presentation, 5-May-08 12:00pm ET

Brief Excerpt: ... - Deutsche Bank - AnalystGood afternoon, everyone, and welcome to Deutsche Bank's healthcare conference. I'm Tao Levy, their medtech analyst, and we're very excited and honored to have with us the management of Johnson & Johnson to kick off the list of medtech companies that are going to be presenting at the conference over the next few days. As you all well know, J&J is a leading player in the worldwide pharmaceuticals, medical device and consumer product market. They have strong franchises in just two many markets to really mention. And today we're lucky to have one of the critical members of J&J's pharmaceutical division; David Norton is the Company's Group Chairman for the Pharmaceuticals Division. And also joining us from J&J is Leslie Fishman, who is part of their Investor Relations team. J&J is facing one of the more challenging periods in its history with two major drugs going off patent over the next couple years. While we believe there are some interesting products in the pipeline...

Report Type: Transcript
Source: Thomson StreetEvents
Company: Johnson & Johnson
Ticker: JNJ
Time: 12:00pm ET
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Enter the keyword(s) which you would like to search for within this document and click "Search"  

Also from Thomson StreetEvents

Price: $54.00



  Get FREE Research

Sign up here to receive email alerts for FREE Research from Alacra Partners!


  Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.